Diamyd Medical's CEO purchased 10 000 more shares in the Company
Diamyd Medical’s CEO Ulf Hannelius has purchased 10 000 Series B shares in Diamyd Medical. Hannelius’ holdings thus amount to 50 000 B-shares. ”I intend to subsribe for my full share in the forhtcoming rights issue”, says Ulf Hannelius, President and CEO of Diamyd Medical. “It is natural to increase my shareholding now, so I can participate also with those in the issue.” Wednesday May 3, 2017, is the last day of share trading including right to participate in the rights issue. For further information about the rights issue, see www.diamyd.com. About Diamyd MedicalDiamyd